Copyright
©The Author(s) 2025.
World J Clin Cases. Aug 16, 2025; 13(23): 107279
Published online Aug 16, 2025. doi: 10.12998/wjcc.v13.i23.107279
Published online Aug 16, 2025. doi: 10.12998/wjcc.v13.i23.107279
Table 2 World Health Classification of pulmonary hypertension and treprostinil indications
Group | Indication | Treprostinil use status |
Group 1 | Pulmonary arterial hypertension | Approved |
Group 2 | Pulmonary hypertension due to left heart disease | Has not been tested |
Group 3 | Pulmonary hypertension associated with lung disorders | Off-label use |
Group 4 | Pulmonary hypertension due to pulmonary artery obstructions | Off-label use |
Group 5 | Miscellaneous (unclear or multifactorial mechanisms) | Has not been tested |
- Citation: Mouratidou C, Pavlidis ET, Katsanos G, Kotoulas SC, Tsoulfas G, Mouloudi E, Taitzoglou IA, Galanis IN, Pavlidis TE. Off-label use of treprostinil in adult patients in clinical cases. World J Clin Cases 2025; 13(23): 107279
- URL: https://www.wjgnet.com/2307-8960/full/v13/i23/107279.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i23.107279